Description

 Vildagliptin Tablets 50mg Description

Product name: Vildagliptin tablets (Weidangning)
Packaging specifications: 50mg14 tablets2 plates  Product dosage form: tablets  Packaging unit: box
Approval number: National Medicine Standard H20234620  Drug standard code: 86983124000043
Manufacturer: Shandong Weizhi Baike Pharmaceutical Co., Ltd.
Product barcode: 6939947900439

Vildagliptin is a selective, reversible DPP 4 inhibitor, widely used as a second-line treatment for type 2 diabeteschemicalbook.com. It works by increasing incretin hormones such as GLP-1 and GIP, enhancing insulin secretion and suppressing glucagon release in a glucose-dependent manner.

Developed originally by Novartis (marketed as Galvus in Europe in 2008), it’s now produced generically by Shandong Weizhibai Ke Pharmacy under the brand Weitangning. The tablets are used to support research in:

• Glucose metabolism pathways

• Beta-cell function and insulin secretion

• Efficacy and safety profiles of DPP 4 inhibitors

 Product Specifications

 Mechanism & Pharmacokinetics

• DPP?4 inhibition: boosts GLP-1/GIP levels, enhancing insulin and reducing glucagon

• Rapid absorption: peak plasma levels within 1–2 h, bioavailability ~85%

• Non-accumulating: half-life ~90 min, linear pharmacokinetics

• Safety profile: minimal drug–drug interaction; low incidence of hypoglycemia

 Why Choose Weitangning Vildagliptin?

• Developed by a legitimate generic pharmaceutical manufacturer in China

• Complies with pharma-grade stability and packaging standards

• NMPA-approved, traceable via drug code and barcode

• Ideal for dual purpose pharmacodynamics and pharmacokinetic labs

 Related Research Materials

• Sitagliptin Tablets (DPP 4 Inhibitor)

• Metformin Hydrochloride Tablets (Biguanide)

• Empagliflozin 10 mg Tablets (SGLT 2 Inhibitor)